Healthtech funding in 2024
European Healthtech startup funding raised during 2024.
In 2024, 412 European Healthtech companies closed 425 funding rounds and raised €5.1B in equity funding (excluding debt and grants). Debt rounds added €83M. UK led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 18 Nov 2026.
Equity funding
€5.1B
excl. debt & grants · +€83M debt
Funding rounds
425
Companies
412
Top country
UK
Healthtech: last three years
change vs the year beforeRank among sectors
#6
6.9% of sector funding
Debt financing
€83M
1.6% of total
Top-10 round share
33.9%
of disclosed capital
Rounds ≥ €100M
6
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, 2024 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €423M | 39 |
| Feb | €328M | 56 |
| Mar | €216M | 29 |
| Apr | €257M | 36 |
| May | €862M | 36 |
| Jun | €214M | 27 |
| Jul | €425M | 31 |
| Aug | €364M | 25 |
| Sep | €367M | 39 |
| Oct | €431M | 27 |
| Nov | €407M | 40 |
| Dec | €916M | 40 |
Top countries
by € raisedHealthtech — top countries by capital, 2024 — interactive chart.
Data table
| Healthtech — top countries by capital, 2024 | |
|---|---|
| UK | €1.8B |
| Switzerland | €858M |
| Germany | €612M |
| France | €441M |
| Finland | €392M |
| Netherlands | €265M |
| Belgium | €159M |
| Spain | €129M |
Stage mix
by € raisedHealthtech — stage mix, 2024 — interactive chart.
Data table
| Healthtech — stage mix, 2024 | |
|---|---|
| Other | €2.0B |
| Series B | €861M |
| Series C | €675M |
| Series D+ | €652M |
| Series A | €558M |
| Seed | €307M |
| Debt | €83M |
| Growth/Late | €32M |
| Grant | €31M |
| Pre-Seed | €28M |
Exits & M&A
28 Acquisition · 4 Merger33 exits · €573M disclosed.
| Calypso Biotech | Acquisition | Jan 2024 | €425M |
| Sonio | Acquisition | May 2024 | €86M |
| Lamidey Noury Medical | Acquisition | Nov 2024 | €50M |
| Apotea | Acquisition | Jan 2024 | €12M |
Largest equity rounds
by disclosed amount, 2024| Company | Stage | Date | Amount |
|---|---|---|---|
| Bicycle Therapeutics | Other | May 2024 | €512M |
| Cimeio Therapeutics | Other | Dec 2024 | €282M |
| ŌURA | Series D+ | Dec 2024 | €192M |
| Flo Health | Series C | Jul 2024 | €185M |
| Caresyntax | Series C | Aug 2024 | €164M |
| MMI | Series C | Feb 2024 | €102M |
| Citryll | Series B | Dec 2024 | €85M |
| Agomab Therapeutics | Series D+ | Oct 2024 | €83M |
| Antag Therapeutics | Series A | Dec 2024 | €80M |
| iOnctura | Series B | Jun 2024 | €80M |
Largest debt rounds
debt financing, 2024; not in the equity totalTop investors
most active in 2024, by deal count- High-Tech Gründerfonds (HTGF)10 deals
- Mercia Ventures9 deals
- Venture Kick9 deals
- The Future of Health Grant (FoHG) program8 deals
- Elaia7 deals
- Innovate UK7 deals
- Scottish Enterprise7 deals
- Bpifrance6 deals
- Octopus Ventures6 deals
- Redalpine6 deals
Source: Tech.eu Funding Explorer · data as of 18 Nov 2026 · licence CC BY 4.0 · Methodology